Home › Funds › Boxer Capital Management, LLC › IRD
Boxer Capital Management, LLC position in IRD
OPUS GENETICS INC · Health Care
Boxer Capital Management, LLC reported holding 4,533,660 shares of IRD (OPUS GENETICS INC) in its Q3 2026 13F filing — a position valued at US$21.9M, representing 1.91% of its reported portfolio and ranking #16 among its reported holdings. Boxer Capital Management, LLC has disclosed IRD holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Boxer Capital Management, LLC's IRD position evolved
Boxer Capital Management, LLC first disclosed a stake in IRD in Q1 2026 at 2,250,000 shares (US$10.2M). The position peaked in Q3 2026 at 4,533,660 shares, worth US$21.9M. Across 3 filings, Boxer Capital Management, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 4,533,660 shares valued at US$21.9M — an increase of 1,718,660 shares quarter over quarter.. Notable position changes include a 25% increase in Q2 2026 (shares rose 18% over the following quarter), a 61% increase in Q3 2026 (shares fell 17% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 2.25M | $10.24M | New |
| Q2 2026 | 2.81M | $11.57M | Add |
| Q3 2026 | 4.53M | $21.94M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IRD and 13F data
IRD (OPUS GENETICS INC) is a Health Care company. 68 other funds we track also report a position in IRD — the largest reported positions include BIOS Capital Management, LP (US$17.83B), PERCEPTIVE ADVISORS LLC (US$43.6M), Caligan Partners LP (US$28.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IRD
- BIOS Capital Management, LP 3.68M sh · $17.83B · Q3 2026
- PERCEPTIVE ADVISORS LLC 9.00M sh · $43.56M · Q3 2026
- Caligan Partners LP 5.96M sh · $28.85M · Q3 2026
- Cormorant Asset Management, LP 5.50M sh · $26.62M · Q3 2026
- Nantahala Capital Management, LLC 4.57M sh · $22.12M · Q3 2026
- Trails Edge Capital Partners, LP 2.41M sh · $11.67M · Q3 2026
- Blue Owl Capital Holdings LP 969.61K sh · $4.69M · Q3 2026
- Opaleye Management Inc. 1.12M sh · $4.62M · Q2 2026
- GREAT POINT PARTNERS LLC 776.88K sh · $3.76M · Q3 2026
- ACUTA CAPITAL PARTNERS, LLC 514.11K sh · $2.49M · Q3 2026
- Propel Bio Management, LLC 270.04K sh · $1.31M · Q3 2026
- Stonepine Capital Management, LLC 98.15K sh · $475.03K · Q3 2026
More on Boxer Capital Management, LLC
FAQ
How long has Boxer Capital Management, LLC held IRD?
Boxer Capital Management, LLC has disclosed IRD holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Boxer Capital Management, LLC's current position in IRD?
As of Q3 2026, Boxer Capital Management, LLC holds 4.53M shares of IRD (OPUS GENETICS INC), valued at $21.94M, representing 1.91% of its reported portfolio and ranking #16.
Has Boxer Capital Management, LLC been buying or selling IRD?
In the latest 13F filing (Q3 2026), Boxer Capital Management, LLC increased its position in IRD. The position peaked in Q3 2026 at 4.53M shares.
Which other funds hold IRD?
Other major institutional holders of IRD include BIOS Capital Management, LP, PERCEPTIVE ADVISORS LLC, Caligan Partners LP, among 68 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.